Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03392337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03392337 · ClinicalTrials.gov record · last posted 2019-01-30

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

StatusRecruiting
PhaseNot applicable
Started2017-11-07
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 30, 2019 (before its estimated December 1, 2019 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2017-12-29; most recent amendment 2024-03-14. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-03-14
Status change Recruiting→Completedv2
Trial Details
NCT Number NCT03392337
Lead Sponsor Psoriasis Treatment Center of Central New Jersey
Conditions Psoriasis
Enrollment 30 participants
Start Date 2017-11-07
Primary Completion 2019-12-01 (estimated)
Study Completion 2020-01-01 (estimated)
Updated on ClinicalTrials.gov 2019-01-30